# CytomX Therapeutics, Inc.: Form 8-K, filed Oct 4, 2021

- Company: [CytomX Therapeutics, Inc.](/companies/ctmx.md) (CIK 1501989)
- Form: 8-K
- Filed: 2021-10-04
- Accepted by EDGAR: Oct 4, 2021, 08:46 ET
- Period: 2021-09-29
- Accession: 0001193125-21-290428
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1501989/000119312521290428/d233551d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1501989/000119312521290428/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1501989/000119312521290428/d233551d8k.htm

Filed Oct 4, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-290428. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
